Enhanced ALP activity of MG63 cells cultured on hydroxyapatite-poly(ethylene glycol) hydrogel composites prepared using EDTA-OH
Source abstract
Abstract
In order to obtain a hydroxyapatite (HAp)-poly(ethylene glycol) (PEG) composite, tetra amine-terminated PEG was crosslinked using disuccinimidyl tartrate to obtain a PEG hydrogel. Using two kinds of chelators with different stability constants for Ca ion (N-(2-hydroxyethyl) ethylenediamine-N,N',N'-triacetic acid (EDTA-OH, 8.14), and ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA, 10.96)), calcium phosphate was deposited within PEG hydrogels by heating the chelator-containing calcium phosphate solution at 90 °C. X-ray diffraction analysis showed that the deposited calcium phosphate was HAp. The crystallinity of the HAp deposited using EDTA-OH was low compared with that obtained using EDTA, but the amount of HAp deposited within the PEG hydrogel using EDTA-OH was higher than that deposited using EDTA. Significantly more human osteoblast-like MG-63 cells adhered on the HAp-PEG composite prepared using EDTA-OH than on the HAp-PEG composites prepared using EDTA. Furthermore, the alkaline phosphatase activity of MG-63 cultured on the HAp-PEG composite prepared using EDTA-OH was four times higher than that on the HAp-PEG composite prepared using EDTA. Therefore, the HAp-PEG composite prepared using EDTA-OH has potential as a bone substitute material.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · 3D Printing in Biomedical Research · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. 10.1016/S0960-8974(02)00004-910.1016/S0960-8974(02)00004-9 ↗
2. 10.1002/1521-3773(20020902)41:17 < 3130::AID-ANIE3130 > 3.0.CO;2-110.1002/1521-3773(20020902)41:17 < 3130::AID-ANIE3130 > 3.0.CO;2-1 ↗
3. 10.1021/cr800427g10.1021/cr800427g ↗
4. 10.1246/cl.1998.71110.1246/cl.1998.711 ↗
5. Lin G · Biomed. Mater. · 2012 · 710.5772/2321 ↗
6. 10.1111/j.1151-2916.1994.tb04508.x10.1111/j.1151-2916.1994.tb04508.x ↗
7. 10.1016/j.actbio.2005.09.00710.1016/j.actbio.2005.09.007 ↗
8. 10.4028/www.scientific.net/KEM.529-530.21710.4028/www.scientific.net/KEM.529-530.217 ↗
9. 10.1163/156856299X0088310.1163/156856299X00883 ↗
10. Furuichi K · Sci. Technol. Adv. Mater. · 2006 · 7 · 21910.1016/j.stam.2005.10.008 ↗
11. 10.1016/j.msec.2009.09.01210.1016/j.msec.2009.09.012 ↗
12. 10.1002/jbm.a.3079910.1002/jbm.a.30799 ↗
13. 10.1016/j.biomaterials.2004.07.04810.1016/j.biomaterials.2004.07.048 ↗
14. 10.1002/jbm.a.3146510.1002/jbm.a.31465 ↗
15. 10.1021/ma800476x10.1021/ma800476x ↗
16. 10.1016/j.biomaterials.2004.04.02910.1016/j.biomaterials.2004.04.029 ↗
17. 10.1177/088391150934968810.1177/0883911509349688 ↗
18. 10.1021/cg200917y10.1021/cg200917y ↗
19. 10.1163/156856299X0039710.1163/156856299X00397 ↗
20. 10.1007/s11003-007-0020-510.1007/s11003-007-0020-5 ↗
21. 10.1002/(SICI)1097-4636(20000605)50:3 < 344::AID-JBM8 > 3.0.CO;2-D10.1002/(SICI)1097-4636(20000605)50:3 < 344::AID-JBM8 > 3.0.CO;2-D ↗
22. 10.1016/0022-0248(91)90673-S10.1016/0022-0248(91)90673-S ↗
23. 10.1007/BF0012029510.1007/BF00120295 ↗
24. 10.1021/la401541p10.1021/la401541p ↗
25. 10.1002/jbm.1017610.1002/jbm.10176 ↗
26. 10.1039/c2jm33036a10.1039/c2jm33036a ↗
27. 10.1016/S0142-9612(00)00174-510.1016/S0142-9612(00)00174-5 ↗
28. 10.1007/s10856-009-3830-110.1007/s10856-009-3830-1 ↗